Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Antidepressant activity of fingolimod in mice.
The role of microglial activation in disease progression.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
New management algorithms in multiple sclerosis.
Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
Early development of anti-natalizumab antibodies in MS patients.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Torque teno mini virus infection and multiple sclerosis.
What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.
Control of TH17 cells occurs in the small intestine.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Pages
« first
‹ previous
…
228
229
230
231
232
233
234
235
236
…
next ›
last »